APA (7th ed.) Citation

King, G. G., Baker, K. K., Coveler, A. L., Harris, W. P., Cohen, S. A., Shankaran, V., . . . Schneider, B. P. (2025). Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers. Cancers, 17(11), 1830. https://doi.org/10.3390/cancers17111830

Chicago Style (17th ed.) Citation

King, Gentry G., et al. "Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers." Cancers 17, no. 11 (2025): 1830. https://doi.org/10.3390/cancers17111830.

MLA (9th ed.) Citation

King, Gentry G., et al. "Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers." Cancers, vol. 17, no. 11, 2025, p. 1830, https://doi.org/10.3390/cancers17111830.